Motor function daily living skills 5 years after paediatric arterial ischaemic stroke: a prospective longitudinal study.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
02 2019
Historique:
accepted: 10 04 2018
pubmed: 31 5 2018
medline: 26 3 2019
entrez: 31 5 2018
Statut: ppublish

Résumé

To describe 5-year motor and functional outcomes after paediatric arterial ischaemic stroke (AIS) and to explore factors associated with poorer long-term outcome. Thirty-three children (21 males, 12 females) with AIS were recruited to a single-site, cross-sectional study, from a previously reported prospective longitudinal stroke outcome study. Children were stratified according to age at diagnosis: neonates (≤30d), preschool (>30d-5y), and school age (≥5y). Motor and functional outcomes were measured at 5 years after stroke. Neurological outcomes were evaluated using the Pediatric Stroke Outcome Measure (PSOM) at 1 month and more than 4 years after stroke. At 5 years after stroke, motor function, quality of life, fatigue, adaptive behaviour, activities of daily living, and handwriting speed were significantly poorer than age expectations. The preschool group had the highest percentage of fine and gross motor impairment. Poorer fine motor skills were associated with subcortical-only lesions and large lesion size. Poorer gross motor outcomes correlated with preschool age, bilateral lesions, and PSOM impairment at 1 month. Children are at elevated risk for motor and functional impairments after AIS, with the preschool age group most vulnerable. Identifying early predictors of poorer outcomes facilitates targeted early intervention and long-term rehabilitation. Following paediatric stroke, children are at elevated risk of motor and functional difficulties. Stroke occurring between 30 days and 5 years of age may result in poorer motor and functional outcomes.

Identifiants

pubmed: 29845603
doi: 10.1111/dmcn.13915
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

161-167

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 Mac Keith Press.

Auteurs

Anna N Cooper (AN)

Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Vic., Australia.
University of Melbourne, Melbourne, Vic., Australia.

Vicki Anderson (V)

Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Vic., Australia.
University of Melbourne, Melbourne, Vic., Australia.
The Royal Children's Hospital, Melbourne, Vic., Australia.

Mardee Greenham (M)

Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Vic., Australia.
University of Melbourne, Melbourne, Vic., Australia.

Stephen Hearps (S)

Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Vic., Australia.
University of Melbourne, Melbourne, Vic., Australia.

Rod W Hunt (RW)

Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Vic., Australia.
University of Melbourne, Melbourne, Vic., Australia.
The Royal Children's Hospital, Melbourne, Vic., Australia.

Mark T Mackay (MT)

Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Vic., Australia.
University of Melbourne, Melbourne, Vic., Australia.
The Royal Children's Hospital, Melbourne, Vic., Australia.

Michael Ditchfield (M)

Monash Medical Centre, Southern Health, Melbourne, Vic., Australia.
Monash University, Melbourne, Vic., Australia.

Lee Coleman (L)

Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Vic., Australia.
The Royal Children's Hospital, Melbourne, Vic., Australia.
Monash Medical Centre, Southern Health, Melbourne, Vic., Australia.

Paul Monagle (P)

Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Vic., Australia.
University of Melbourne, Melbourne, Vic., Australia.
The Royal Children's Hospital, Melbourne, Vic., Australia.

Anne L Gordon (AL)

Evelina London Children's Hospital, Guy's and St Thomas', NHS Foundation Trust, London, UK.
Kings College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH